Imatinib, marketed as Glivec in Europe and Gleevec in the US, has been used to treat myeloid leukaemia (CML) and gastrointestinal stromal tumor (GIST) since 2001.

• 伊马替尼，推销作为格列卫在欧洲和伊马替尼在美国，已被用来治疗骨髓性白血病（慢性骨髓性白血病）和胃肠道间质肿瘤（ gist ）的，自2001年以来。